Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Plos One
|
August 26, 2014
RNA-sequencing analysis of HepG2 cells treated with atorvastatin
Camilla Stormo, Marianne K Kringen, Robert Lyle, et al.
Acta Ophthalmologica
|
July 18, 2008
Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
Dag S Fosmark, Jens P Berg, Aase-Brith Jensen, et al.
Chemosphere
|
December 5, 2022
Do changes in persistent organic pollutants after bariatric surgery cause endocrine disruption?
Aina Jansen, Jan O Aaseth, Jan L Lyche, et al.
Acta Ophthalmologica Scandinavica
|
May 10, 2007
Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study
Dag S Fosmark, Ragnheidur Bragadóttir, Ingar Stene-Johansen, et al.
Bone
|
December 1, 2012
Identification of transcriptional macromolecular associations in human bone using browser based in silico analysis in a giant correlation matrix
Sjur Reppe, Daniel Sachse, Ole K Olstad, et al.
American Journal of Hematology
|
February 26, 2011
Full-disclosure in industry-sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Transfusion
|
June 13, 2012
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Clinical Chemistry and Laboratory Medicine
|
December 16, 2010
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Clinical Chemistry
|
December 22, 2010
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
December 23, 2010
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Plos One
|
August 26, 2014
RNA-sequencing analysis of HepG2 cells treated with atorvastatin
Camilla Stormo, Marianne K Kringen, Robert Lyle, et al.
Acta Ophthalmologica
|
July 18, 2008
Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
Dag S Fosmark, Jens P Berg, Aase-Brith Jensen, et al.
Chemosphere
|
December 5, 2022
Do changes in persistent organic pollutants after bariatric surgery cause endocrine disruption?
Aina Jansen, Jan O Aaseth, Jan L Lyche, et al.
Acta Ophthalmologica Scandinavica
|
May 10, 2007
Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study
Dag S Fosmark, Ragnheidur Bragadóttir, Ingar Stene-Johansen, et al.
Bone
|
December 1, 2012
Identification of transcriptional macromolecular associations in human bone using browser based in silico analysis in a giant correlation matrix
Sjur Reppe, Daniel Sachse, Ole K Olstad, et al.
American Journal of Hematology
|
February 26, 2011
Full-disclosure in industry-sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Transfusion
|
June 13, 2012
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Clinical Chemistry and Laboratory Medicine
|
December 16, 2010
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Clinical Chemistry
|
December 22, 2010
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
December 23, 2010
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors
Nader Rifai, Mario Plebani, Alan Wu, et al.
Page
of 6